Cold Spring Harbor Laboratory (CSHL) Professor and Cancer Center Director David Tuveson was elected to the National Academy of Medicine (NAM) on October 17, 2022. He was recognized for his leadership in pancreatic cancer research.
Tuveson’s pioneering work with cancer organoids—miniature versions of tumors—led to the development of the first mouse models for two types of pancreatic cancer. In 2020, he helped found the CSHL organoid facility, which develops and stores organoids for cancer research at CSHL and abroad. These shared resources have been essential for preclinical studies of targeted cancer therapies and treatments.
“It is an unexpected honor to join the august group of members in the National Academy of Medicine,” he says. “This election reflects the notable advances our laboratory has made over the past 21 years. We could not have made progress without the incredibly stimulating and supportive environment at Cold Spring Harbor Laboratory—as well as the steadfast support of the Lustgarten Foundation, the National Cancer Institute, and a synergistic partnership with Northwell Health.”
Tuveson joins CSHL Professor Adrian Krainer, who was elected to the NAM in 2019. Founded in 1970, the NAM works to improve global health by advancing science, accelerating health equity, and providing independent, authoritative advice. Its members have made major contributions to medicine, healthcare, and public health.